Investor Novo Holdings A/S
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Novo Holdings A/S . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-19 13D/A IOBT / IO Biotech, Inc. 5,823,584 4,981,588
2025-08-14 13G/A 1,872,142
2025-04-01 13G ZBIO / Zenas BioPharma, Inc. 2,214,967
2025-02-14 13G 1,750,000
2025-01-16 13D/A 2,497,791 99,913
2024-11-22 13G/A EXAI / Exscientia plc - Depositary Receipt (Common Stock) 0
2024-09-23 13D/A EWTX / Edgewise Therapeutics, Inc. 6,344,430 5,549,900
2024-09-17 13D/A IOBT / IO Biotech, Inc. 6,898,584 5,823,584
2024-06-24 13D/A GLTO / Galecto, Inc. 2,497,791 2,497,791
2024-05-14 13G/A IOBT / IO Biotech, Inc. 7,557,393 6,898,584
2024-03-28 13D/A SPRB / Spruce Biosciences, Inc. 2,756,000 1,656,000
2024-03-25 13D/A SPRB / Spruce Biosciences, Inc. 4,671,021 2,756,000
2024-03-20 13D/A SPRB / Spruce Biosciences, Inc. 6,466,020 4,671,021
2024-03-18 13D/A SPRB / Spruce Biosciences, Inc. 8,378,336 6,466,020
2024-03-07 13D/A LVTX / LAVA Therapeutics N.V. 1,878,194 0
2024-02-14 13G/A EVO / Evotec SE - Depositary Receipt (Common Stock) 17,444,807 14,931,858
2024-02-13 13D/A IOBT / IO Biotech, Inc. 8,216,202 7,557,393
2024-01-25 13D/A EWTX / Edgewise Therapeutics, Inc. 6,071,703 6,344,430
2024-01-02 13G/A RLYB / Rallybio Corporation 2,296,007 1,767,861
2023-12-15 13D/A RPHM / Reneo Pharmaceuticals, Inc. 3,430,377 0
2023-12-15 13G/A LXEO / Lexeo Therapeutics, Inc. 1,294,053 1,307,829
2023-11-24 13G LXEO / Lexeo Therapeutics, Inc. 1,294,053
2023-11-09 13D/A LVTX / LAVA Therapeutics N.V. 2,400,000 1,878,194
2023-08-11 13D/A IOBT / IO Biotech, Inc. 3,277,932 8,216,202
2023-08-03 13D/A CYTT / Cyteir Therapeutics, Inc. 3,072,136 1,547,136
2023-07-26 13D/A CYTT / Cyteir Therapeutics, Inc. 3,940,413 3,072,136
2023-06-28 13G/A IRON / Disc Medicine, Inc. 2,340,772 1,090,772
2023-06-28 13G/A GRTX / Galera Therapeutics, Inc. 2,459,021 2,100,000
2023-06-28 13D/A EWTX / Edgewise Therapeutics, Inc. 6,071,703 6,071,703
2023-06-06 13D/A LVTX / LAVA Therapeutics N.V. 3,070,558 2,400,000
2023-05-26 13G/A VECT / VectivBio Holding AG 3,339,484 0
2023-05-15 13D/A RPHM / Reneo Pharmaceuticals, Inc. 3,430,377 3,430,377
2023-02-24 13D/A LVTX / LAVA Therapeutics N.V. 3,327,312 3,070,558
2023-02-21 13D/A SPRB / Spruce Biosciences, Inc. 4,514,336 8,378,336
2023-02-17 13G LNZA / LanzaTech Global, Inc. 15,814,845
2023-02-02 13G/A VECT / VectivBio Holding AG 3,339,484
2023-02-02 13G/A EVO / Evotec SE - Depositary Receipt (Common Stock) 17,894,807 17,444,807
2023-01-04 13D/A BOLT / Bolt Biotherapeutics, Inc. 2,534,465 0
2023-01-03 13G IRON / Disc Medicine, Inc. 2,340,772
2022-12-28 13D/A BOLT / Bolt Biotherapeutics, Inc. 3,703,991 2,534,465
2022-12-12 13G/A ACLX / Arcellx, Inc. 2,507,076 1,750,000
2022-11-28 13G/A ACLX / Arcellx, Inc. 4,016,878 2,507,076
2022-11-17 13G RLYB / Rallybio Corporation 2,296,007
2022-11-03 13G/A UTRS / Minerva Surgical, Inc. 2,057,132 1,322,473
2022-10-24 13D/A MIST / Milestone Pharmaceuticals Inc. 2,097,713 1,378,538
2022-10-03 13D/A LVTX / LAVA Therapeutics N.V. 3,327,312 3,327,312
2022-09-30 13D/A SPRB / Spruce Biosciences, Inc. 4,514,336 4,514,336
2022-09-30 13D/A GLTO / Galecto, Inc. 2,497,791 2,497,791
2022-09-30 13D/A IOBT / IO Biotech, Inc. 3,277,932 3,277,932
2022-09-30 13D/A BOLT / Bolt Biotherapeutics, Inc. 3,703,991 3,703,991
2022-09-30 13D/A EWTX / Edgewise Therapeutics, Inc. 6,071,703 6,071,703
2022-09-30 13D/A RPHM / Reneo Pharmaceuticals, Inc. 3,430,377 3,430,377
2022-09-30 13D/A LVTX / LAVA Therapeutics N.V. 3,327,312 3,327,312
2022-09-30 13D/A CYT / Cyteir Therapeutics, Inc. 3,940,413 3,940,413
2022-09-26 13D/A MIST / Milestone Pharmaceuticals Inc. 2,080,885 2,097,713
2022-09-16 13D/A EWTX / Edgewise Therapeutics, Inc. 5,587,207 6,071,703
2022-08-18 13D/A MIRM / Mirum Pharmaceuticals, Inc. 1,889,127 1,760,000
2022-08-02 13D/A MIRM / Mirum Pharmaceuticals, Inc. 2,200,000 1,889,127
2022-07-25 13D/A CYT / Cyteir Therapeutics, Inc. 4,840,413 3,940,413
2022-07-15 13D/A BOLT / Bolt Biotherapeutics, Inc. 4,503,991 3,703,991
2022-06-03 13D/A CMPI / Checkmate Pharmaceuticals Inc 1,828,484 0
2022-06-03 13D/A NKTX / Nkarta, Inc. 2,238,309 2,238,309
2022-05-26 13D/A IOBT / IO Biotech, Inc. 3,277,932 3,277,932
2022-05-11 13D/A CMPI / Checkmate Pharmaceuticals Inc 2,170,100 1,828,484
2022-05-02 13D/A NKTX / Nkarta, Inc. 2,793,865 2,238,309
2022-04-08 13D/A MIRM / Mirum Pharmaceuticals, Inc. 2,445,147 2,200,000
2022-02-22 13D/A MORF / Morphic Holding, Inc. 2,050,446 1,845,030
2022-02-09 13G ACLX / Arcellx, Inc. 4,016,878
2022-02-02 13G / Exscientia plc 13,086,600
2022-02-02 13G EVTCY / Evotec SE - ADR 17,894,807
2022-02-02 13G/A GRTX / Galera Therapeutics, Inc. 2,959,021 2,459,021
2022-01-31 13D/A ALGS / Aligos Therapeutics, Inc. 2,614,563 1,950,000
2022-01-27 13D/A RPHM / Reneo Pharmaceuticals, Inc. 3,430,377 3,430,377
2021-12-20 13D/A CYT / Cyteir Therapeutics, Inc. 4,840,413 4,840,413
2021-11-22 13D/A SPRB / Spruce Biosciences, Inc. 4,514,336 4,514,336
2021-11-22 13D/A NKTX / Nkarta, Inc. 2,793,865 2,793,865
2021-11-22 13D/A BOLT / Bolt Biotherapeutics, Inc. 4,503,991
2021-11-10 13D IOBT / IO Biotech, Inc. 3,277,932
2021-11-02 13G/A 1,785,563
2021-11-01 13D/A CMPI / Checkmate Pharmaceuticals Inc 2,170,100 2,170,100
2021-11-01 13D/A MORF / Morphic Holding, Inc. 2,050,446 2,050,446
2021-10-27 13G UTRS / Minerva Surgical, Inc. 2,057,132
2021-09-20 13G/A INGN / Inogen, Inc. 3,549,320 1,079,320
2021-08-24 13D/A MIRM / Mirum Pharmaceuticals, Inc. 2,445,147 2,445,147
2021-08-12 13D/A MORF / Morphic Holding, Inc. 2,645,446 2,050,446
2021-07-30 13D/A INZY / Inozyme Pharma, Inc. 1,969,379 1,167,706
2021-06-25 13D CYT / Cyteir Therapeutics, Inc. 4,840,413
2021-06-21 13D/A ALGS / Aligos Therapeutics, Inc. 2,614,563 2,614,563
2021-05-21 13G/A HRMY / Harmony Biosciences Holdings, Inc. 3,622,471 2,416,254
2021-05-21 13D/A SPRB / Spruce Biosciences, Inc. 4,989,336 4,514,336
2021-05-03 13G/A PRAX / Praxis Precision Medicines, Inc. 2,442,080 1,442,080
2021-04-14 13D RPHM / Reneo Pharmaceuticals, Inc. 3,430,377
2021-03-31 13D LVTX / LAVA Therapeutics N.V. 3,327,312
2021-03-31 13D EWTX / Edgewise Therapeutics, Inc. 5,587,207
2021-03-30 13D/A INZY / Inozyme Pharma, Inc. 2,194,379 1,969,379
2021-03-11 13D/A MORF / Morphic Holding, Inc. 2,645,446 2,645,446
2021-02-17 13G/A INGN / Inogen, Inc. 3,549,320 3,549,320
2021-02-08 13G PRAX / Praxis Precision Medicines, Inc. 2,442,080
2021-02-08 13G/A HRMY / Harmony Biosciences Holdings, Inc. 3,754,973 3,622,471
2021-02-08 13G/A GRTX / Galera Therapeutics, Inc. 3,409,021 2,959,021
2021-02-05 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 22,639,667 12,893,250
2021-02-01 13D/A INZY / Inozyme Pharma, Inc. 2,569,379 2,194,379
2020-12-30 13G/A SPNE / SeaSpine Holdings Corp 1,658,037 1,346,487
2020-12-18 13D/A MIRM / Mirum Pharmaceuticals, Inc. 2,445,147 2,445,147
2020-11-05 13D GLTO / Galecto, Inc. 2,497,791
2020-10-22 13D ALGS / Aligos Therapeutics, Inc. 2,614,563
2020-10-16 13D SPRB / Spruce Biosciences, Inc. 4,989,336
2020-10-05 13D/A INZY / Inozyme Pharma, Inc. 2,569,379 2,569,379
2020-10-05 13D/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 23,048,499 22,639,667
2020-10-05 13D/A INZY / Inozyme Pharma, Inc. 2,569,379
2020-09-04 13G/A HRMY / Harmony Biosciences Holdings, Inc. 4,409,803 3,754,973
2020-08-25 13G HRMY / Harmony Biosciences Holdings, Inc. 4,409,803
2020-08-13 13D CMPI / Checkmate Pharmaceuticals Inc 2,170,100
2020-08-11 13G/A ETTX / Entasis Therapeutics Holdings Inc 2,181,843 1,173,896
2020-07-29 13D INZY / Inozyme Pharma, Inc. 2,569,379
2020-07-24 13D/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 14,159,611 23,048,499
2020-07-16 13D NKTX / Nkarta, Inc. 2,793,865
2020-07-09 13D/A CRVS / Corvus Pharmaceuticals, Inc. 2,927,560 1,389,498
2020-06-16 13G/A ETTX / Entasis Therapeutics Holdings Inc 2,181,843 2,181,843
2020-03-12 13D/A MIST / Milestone Pharmaceuticals Inc. 2,434,470 2,080,885
2020-02-05 13G/A ETTX / Entasis Therapeutics Holdings Inc 2,181,843 2,181,843
2020-02-05 13G/A GRTX / Galera Therapeutics, Inc. 3,409,021 3,409,021
2020-02-05 13G/A INGN / Inogen, Inc. 3,549,320 3,549,320
2020-02-05 13G/A SPNE / SeaSpine Holdings Corp 1,308,037 1,658,037
2020-01-17 13D/A MIRM / Mirum Pharmaceuticals, Inc. 2,445,147 2,445,147
2019-11-27 13D/A MIST / Milestone Pharmaceuticals Inc. 2,674,470 2,434,470
2019-11-14 13G GRTX / Galera Therapeutics, Inc. 3,409,021
2019-09-20 13D/A MIST / Milestone Pharmaceuticals Inc. 2,674,470 2,674,470
2019-07-29 13D/A CRVS / Corvus Pharmaceuticals, Inc. 4,420,516 2,927,560
2019-07-23 13D MIRM / Mirum Pharmaceuticals, Inc. 2,445,147
2019-07-01 13G/A NBRV / Nabriva Therapeutics Plc 4,703,720 3,446,564
2019-07-01 13D MORF / Morphic Holding, Inc. 2,645,446
2019-05-14 13D MIST / Milestone Pharmaceuticals Inc. 2,674,470
2019-04-02 13D VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 14,159,611 14,159,611
2019-02-01 13G/A NBRV / Nabriva Therapeutics Plc 2,924,822 4,703,720
2019-02-01 13G/A SPNE / SeaSpine Holdings Corp 882,332 1,308,037
2019-01-31 13D/A CRVS / Corvus Pharmaceuticals, Inc. 3,154,046 4,420,516
2019-01-07 13G/A AKBA / Akebia Therapeutics, Inc. 2,481,400 3,100,000
2019-01-07 13G/A VYNE / VYNE Therapeutics Inc. 0
2018-12-13 13G/A KIDS / OrthoPediatrics Corp. 653,349 654,549
2018-10-29 13G/A IVTY / Invuity, Inc. 1,363,848 0
2018-10-01 13G ETTX / Entasis Therapeutics Holdings Inc 2,181,843
2018-07-27 13D/A MRUS / Merus N.V. 1,410,417 1,102,795
2018-07-02 13G KIDS / OrthoPediatrics Corp. 653,349
2018-03-02 13D/A RARX / Ra Pharmaceuticals, Inc. 2,031,562 1,531,562
2018-02-26 13D/A RARX / Ra Pharmaceuticals, Inc. 2,031,562 2,031,562
2018-02-26 13G SPNE / SeaSpine Holdings Corp 882,332
2018-02-13 13G AKBA / Akebia Therapeutics, Inc. 2,481,400 2,481,400
2018-02-12 13G AKBA / Akebia Therapeutics, Inc. 1,516,387 2,481,400
2018-02-08 13G VYNE / VYNE Therapeutics Inc. 1,161,182
2018-02-06 13G/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 14,159,611
2018-02-02 13G/A NBRV / Nabriva Therapeutics Plc 232,655 2,924,822
2018-02-02 13G/A INGN / Inogen, Inc. 3,549,320 3,549,320
2018-02-02 13G/A IVTY / Invuity, Inc. 1,318,448 1,363,848
2017-11-13 13D/A RETA / Reata Pharmaceuticals Inc - Class A 1,794,763 0
2017-10-13 13D/A KALV / KalVista Pharmaceuticals, Inc. 2,725,283 0
2017-09-22 13D/A KALV / KalVista Pharmaceuticals, Inc. 2,901,927 2,725,283
2017-08-29 13D/A HTGM / HTG Molecular Diagnostics Inc 1,199,599 49,786
2017-08-23 13D/A RARX / Ra Pharmaceuticals, Inc. 2,031,562 2,031,562
2017-08-23 13D/A HTGM / HTG Molecular Diagnostics Inc 1,280,185 1,199,599
2017-08-16 13D/A APEN / Apollo Endosurgery Inc 1,081,072 671,872
2017-08-14 13D/A APEN / Apollo Endosurgery Inc 1,290,193 1,081,072
2017-08-03 13D/A RETA / Reata Pharmaceuticals Inc - Class A 1,794,763 1,794,763
2017-07-28 13G OBSV / ObsEva SA. 916,489
2017-07-27 13D/A APEN / Apollo Endosurgery Inc 1,456,972 1,290,193
2017-07-20 13D/A MRUS / Merus N.V. 1,410,417 1,410,417
2017-07-20 13D/A HTGM / HTG Molecular Diagnostics Inc 1,280,185 1,280,185
2017-07-19 13D/A HTGM / HTG Molecular Diagnostics Inc 1,280,185 1,280,185
2017-07-19 13D/A MRUS / Merus N.V. 1,410,417 1,410,417
2017-06-26 13D/A RETA / Reata Pharmaceuticals Inc - Class A 2,994,763 1,794,763
2017-06-15 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,367,763 2,994,763
2017-05-09 13G VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 14,159,611
2017-05-09 13G VNAPF / Verona Pharma Plc 14,159,611
2017-05-09 13G/A IRTC / iRhythm Technologies, Inc. 2,024,448 0
2017-04-20 13D/A CLCD / CoLucid Pharmaceuticals, Inc. 3,156,563 0
2017-03-31 13D/A HTGM / HTG Molecular Diagnostics Inc 1,280,185 1,280,185
2017-03-10 13D/A HTGM / HTG Molecular Diagnostics Inc 1,280,185 1,280,185
2017-03-03 13D/A APEN / Apollo Endosurgery Inc 1,456,972 1,456,972
2017-03-03 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,367,763 3,367,763
2017-03-03 13D/A MRUS / Merus N.V. 1,410,417 1,410,417
2017-02-08 13G IRTC / iRhythm Technologies, Inc. 2,024,448
2017-02-08 13G/A INGN / Inogen, Inc. 3,549,320 3,549,320
2017-02-08 13G/A NBRV / Nabriva Therapeutics Plc 106,511 232,655
2017-02-08 13G/A IVTY / Invuity, Inc. 925,000 1,318,448
2017-01-04 13D APEN / Apollo Endosurgery Inc 1,456,972
2016-12-19 13D/A ISEE / IVERIC bio Inc 3,610,487 0
2016-12-09 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,367,763 3,367,763
2016-11-30 13D KALV / KalVista Pharmaceuticals, Inc. 2,901,927
2016-11-03 13D RARX / Ra Pharmaceuticals, Inc. 2,031,562
2016-09-14 13D/A CLCD / CoLucid Pharmaceuticals, Inc. 3,056,563 3,156,563
2016-08-10 13G/A TBRA / Tobira Therapeutics, Inc. 2,471,405 173,905
2016-08-05 13D/A RETA / Reata Pharmaceuticals Inc - Class A 3,367,763 3,367,763
2016-07-29 13G NBRV / Nabriva Therapeutics Plc 106,511
2016-06-02 13D RETA / Reata Pharmaceuticals Inc - Class A 3,367,763
2016-06-02 13D/A MRUS / Merus N.V. 1,407,399 1,410,417
2016-05-31 13D/A ISEE / IVERIC bio Inc 4,910,489 3,610,487
2016-05-26 13D MRUS / Merus N.V. 1,407,399
2016-03-30 13D CRVS / Corvus Pharmaceuticals, Inc. 3,154,046
2016-02-12 13G/A TBRA / Tobira Therapeutics, Inc. 2,696,405 2,471,405
2016-02-10 13G/A ELDN / Eledon Pharmaceuticals, Inc. 470,946
2016-02-10 13G/A IVTY / Invuity, Inc. 740,942 925,000
2016-02-10 13G/A ELDN / Eledon Pharmaceuticals, Inc. 470,946
2015-11-18 13D/A AKBA / Akebia Therapeutics, Inc. 1,516,387 1,516,387
2015-09-30 13D/A FLXN / Horizon Funds - Horizon Flexible Income ETF 2,283,131 1,033,131
2015-09-14 13G/A NVRO / Nevro Corp. 625,704
2015-07-02 13G/A ALDR / Alder BioPharmaceuticals, Inc. 1,951,183
2015-06-29 13G IVTY / Invuity, Inc. 740,942
2015-06-16 13D/A AKBA / Akebia Therapeutics, Inc. 1,516,387
2015-06-12 13G/A OTIC / Otonomy Inc 875,025
2015-05-13 13D CLCD / CoLucid Pharmaceuticals, Inc. 3,056,563
2015-05-13 13D HTGM / HTG Molecular Diagnostics Inc 1,280,185
2015-05-13 13G TBRA / Tobira Therapeutics, Inc. 2,696,405
2015-04-30 13G/A INGN / Inogen, Inc. 3,549,320
2015-04-30 13D/A FLXN / Horizon Funds - Horizon Flexible Income ETF 2,283,131
2015-03-11 13D/A ISEE / IVERIC bio Inc 4,910,489
2015-02-02 13G NVRO / Nevro Corp. 2,194,841
2015-02-02 13G ALDR / Alder BioPharmaceuticals, Inc. 3,201,183
2015-02-02 13G INGN / Inogen, Inc. 3,549,320
2014-12-18 13D/A FLXN / Horizon Funds - Horizon Flexible Income ETF 2,283,131
2014-11-18 13D/A ISEE / IVERIC bio Inc 5,915,489
2014-10-22 13G ELDN / Eledon Pharmaceuticals, Inc. 1,149,706
2014-08-28 13G OTIC / Otonomy Inc 2,175,025
2014-04-03 13D AKBA / Akebia Therapeutics, Inc. 1,516,387
2014-02-26 13D FLXN / Horizon Funds - Horizon Flexible Income ETF 1,783,131
2014-02-24 13D/A ISEE / IVERIC bio Inc 6,910,489
2013-10-10 13D ISEE / IVERIC bio Inc 6,910,489
2012-12-03 13D/A BMTI / Biomimetic Therapeutics, Inc. 4,720,065